raps23h ago1 min read

Recon: FDA orders new eye risk warnings for Ozempic, Zepbound; FDA launches investigation of Novartis’ Zolgensma after cancer ca...

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

source

Reporting by raps.

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

raps23h ago1 min read

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

source

Reporting by raps.

5-min edit window · permanent after that

no comments yet — first sniff?